Dishman Pharma in demand on reporting 10-fold increase in Q3 consolidated net

Dishman Pharmaceuticals and Chemicals is currently trading at Rs. 61.50, up by 1.60 points or 2.67% from its previous closing of Rs. 59.90 on the BSE.

The scrip opened at Rs. 61.90 and has touched a high and low of Rs. 63.60 and Rs. 61.30 respectively. So far 191824 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 120.40 on 11-Feb-2011 and a 52 week low of Rs. 32.50 on 23-Dec-2011.

Last one week high and low of the scrip stood at Rs. 65.10 and Rs. 51.75 respectively. The current market cap of the company is Rs. 495.88 crore.

The promoters holding in the company stood at 61.36% while Institutions and Non-Institutions held 10.64% and 28.00% respectively. 

Dishman Pharmaceuticals and Chemicals has reported about 10-fold increase in its consolidated net profit at Rs 16.72 crore for the quarter ended December 31. The company had posted a net profit of Rs 1.68 crore in the corresponding period last financial year.

The consolidated total income during the quarter under review also went up by 11.89% to Rs 266.19 crore from Rs 237.89 crore in the year-ago period.